Aspirins May Protect Liver; hepatocellular carcinoma

Painkillers May Protect Liver
MedPage Today
Aspirin users were 41% less likely to develop hepatocellular carcinoma and 45% less likely to die from chronic liver disease than non-users, both statistically significant differences, Vikrant V. Sahasrabuddhe, MBBS, DrPH, of the National Cancer ...

Tivantinib Shows Modest Benefit in Relapsed Liver Cancer
The Oncology Report
BOSTON - The investigational drug tivantinib was associated with a modest but statistically significant slowing of time to progression as a second-line agent against hepatocellular carcinoma, investigators reported. Tivantinib, a c-MET inhibitor ...

Sponsored Links: